Registry for evaluating Medtronic products

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to continuously evaluate and report on the safety and effectiveness of Medtronic products that are already on the market. It collects data to support patients, hospitals, clinicians, and regulatory bodies by streamlining the clinical surveillance process. The registry allows for performance assessment of these products with minimal burden on participants. It includes patients who are currently receiving or are intended to receive eligible Medtronic products.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
* Patient has or is intended to receive or be treated with an eligible Medtronic product
* Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Exclusion Criteria:

* Patient who is, or will be, inaccessible for follow-up
* Patient with exclusion criteria required by local law
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Where it's running

• Birmingham, Alabama, United States Recruiting
• Huntsville, Alabama, United States Recruiting
• Chandler, Arizona, United States Recruiting
• Phoenix, Arizona, United States Recruiting
• Little Rock, Arkansas, United States Recruiting
• Aliso Viejo, California, United States Recruiting

+352 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Medtronic Product Surveillance Registry
• Email: rs.productsurveillanceregistry@medtronic.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Supira System in high-risk PCI: a pivotal comparison to Impella

  This study tests whether the Supira System can safely and effectively support the heart during high-risk PCI, compared with the currently available Impella device.

  Recruiting at 26 sites Supira Medical · Loma Linda, California and 25 other locations · NCT07296744

• μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease

  This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.

  Recruiting Centro Cardiologico Monzino · Cosenza, CS and 3 other locations · NCT07917234

• Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents

  This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.

  Recruiting Adiyaman University · Adıyaman · NCT07898215

• Can preoperative photon-counting CT help predict heart recovery after bypass surgery?

  This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07883499

• Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease

  This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.

  Recruiting at 5 sites Hospital Arnau de Vilanova · Mexico City, Mexico City and 4 other locations · NCT07875088

• Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance

  This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.

  Recruiting University of Gaziantep · Gaziantep · NCT07871201

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.